Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: Preliminary results in Vietnam

被引：0
|
作者：
Hoang, G. H. Nguyen [1 ]
Nguyen, P. T. B. [2 ]
Nguyen, H. T. N. [2 ]
Do, K. H. [2 ]
机构：
[1] Hanoi Oncol Hosp, Med Dept 1, Hanoi, Vietnam
[2] K Hosp, Med Dept 1, Hanoi, Vietnam
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
275P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma
    Akiyama, Hiroki
    Takase, Hiroshi
    Kubo, Fumito
    Miki, Tohru
    Yamamoto, Masahide
    Tomita, Makoto
    Mochizuki, Manabu
    Miura, Osamu
    Arai, Ayako
    CANCER SCIENCE, 2016, 107 (10) : 1458 - 1464
  • [42] Preliminary Results of Penpulimab Combined with RMA (rituximab, methotrexate, and cytarabine) for Newly Diagnosed Primary Central Nervous System Lymphoma
    Shen, Haorui
    Wu, Jia-Zhu
    Liang, Jin-Hua
    Yin, Hua
    Wang, Li
    Li, Jianyong
    Xu, Wei
    BLOOD, 2022, 140 : 3821 - 3822
  • [43] Rituximab Cerebrospinal Fluid Levels in Patients with Primary Central Nervous System Lymphoma Treated with Intravenous High Dose Rituximab
    Larouche, Jean-Francois
    Bergeron, Marc
    Hampson, Grace
    Illidge, Tim
    Delage, Robert
    BLOOD, 2011, 118 (21) : 714 - 714
  • [44] A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy
    Biswas, Ahitagni
    Adhikari, Narayan
    Bakhshi, Sameer
    Gopinathan, Vikram Raj
    Sharma, Mehar Chand
    PEDIATRIC NEUROSURGERY, 2019, 54 (01) : 57 - 65
  • [45] LATE RELAPSES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TREATED WITH HHGH DOSE METHOTREXATE
    Ambady, Prakash
    Holdhoff, Matthias
    Ferrigno, Clare
    Grossman, Stuart
    NEURO-ONCOLOGY, 2013, 15 : 98 - 98
  • [46] High-dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China
    Chen, Cui
    Sun, Peng
    Cui, Juan
    Yan, Shumei
    Chen, Hao
    Xia, Yi
    Bi, Xiwen
    Liu, Panpan
    Wang, Yu
    Yang, Hang
    Nie, Man
    Zhang, Xue-Wen
    Jiang, Wenqi
    Li, Zhi-Ming
    CANCER MEDICINE, 2019, 8 (04): : 1359 - 1367
  • [47] DOSE ESCALATION TEMOZOLOMIDE WITH 3D-CRT AFTER HIGH DOSE METHOTREXATE IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: PRELIMINARY RESULTS
    Frascino, V.
    Chiesa, S.
    Manfrida, S.
    Luciana, T.
    Fiorentino, A.
    Hohaus, S.
    De Bari, B.
    Mantini, G.
    D'Agostino, G. R.
    Aristei, C.
    Balducci, M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S258 - S259
  • [48] High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: A preliminary experience
    Falchi, Lorenzo
    Gunnellini, Marco
    Ferranti, Lucia
    Liberati, Anna Marina
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (10) : 1376 - 1378
  • [49] Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy
    Manabu Kinoshita
    Naoya Hashimoto
    Shuichi Izumoto
    Yoshiko Okita
    Naoki Kagawa
    Motohiko Maruno
    Takanori Ohnishi
    Norio Arita
    Toshiki Yoshimine
    Journal of Neuro-Oncology, 2010, 99 : 95 - 101
  • [50] Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy
    Kinoshita, Manabu
    Hashimoto, Naoya
    Izumoto, Shuichi
    Okita, Yoshiko
    Kagawa, Naoki
    Maruno, Motohiko
    Ohnishi, Takanori
    Arita, Norio
    Yoshimine, Toshiki
    JOURNAL OF NEURO-ONCOLOGY, 2010, 99 (01) : 95 - 101
12345